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 Riassunto 
 
Le cellule normali non si replicano all’infinito, piuttosto dopo un certo 
numero di divisioni, entrano in uno stato di arresto permanente della 
proliferazione definito senescenza cellulare.  
La senescenza cellulare è accompagnata da una riprogrammazione del 
profilo di espressione genica, conseguente a modifiche dei 
meccanismi di regolazione che agiscono sia a livello trascrizionale che 
post-trascrizionale così come a livello epigenetico. 
I microRNA (miRs) sono piccoli RNA non codificanti che svolgono 
un ruolo fondamentale nella regolazione negativa dell’espressione 
genica a livello post-trascrizionale. Essi riconoscono sequenze al 
3’UTR e bloccano la traduzione o determinano la degradazione di 
RNA messaggeri.  
Nel laboratorio in precedenza erano stati identificati 24 miRs 
(SAmiRs) up- o down-regolati nella senescenza cellulare di fibroblasti 
primari IMR90. Studi funzionali sui SAmiRs up-regolati avevano 
dimostrato che 5 di essi sono in grado di indurre un fenotipo di 
senescenza precoce quando iper-espressi in cellule giovani, in 
particolare, il miR-494 è quello che provoca il fenotipo senescente più 
marcato.  
I nostri studi hanno perseguito due obiettivi fondamentali:  
i) studiare le vie regolatorie in cui è coinvolto il miR-494 attraverso 
l’identificazione dei suoi targets molecolari;  
ii) identificare nuovi mediatori/effettori comuni della senescenza 
cellulare indotta sia dall’accorciamento dei telomeri che 
provocata dallo stress ossidativo. 
Per entrambi gli obiettivi, è stato scelto un approccio high-throughput 
di tipo proteomico utilizzando la tecnologia del 2D-DIGE (Two  
Dimensional-Difference Gel Electrophoresis) accoppiata alla 
Spettrometria di Massa (LC−MS/MS).  
Nell’ambito del primo obiettivo, per individuare possibili targets del 
miR-494, abbiamo monitorato con il 2D-DIGE i cambiamenti a livello 
proteico conseguenti alla sua iper-espressione nelle cellule IMR90 
giovani, considerando che esiste una relazione inversa tra livelli dei 
miRs e livelli proteici espressi dai loro targets. L’analisi 2D-DIGE ci 
 
 
 ha permesso di considerare circa 1500 spot proteici presenti in 
ambedue le condizioni. Tra questi, 102 spot proteici (38 up- e 64 
down-regolati) sono risultati differenzialmente rappresentati nelle 
cellule trasfettate con il miR-494, comparate con cellule controllo 
trasfettate con un miR-scramble. Con la spettrometria di massa sono 
state identificate 172 specie proteiche differenti, di cui 121 presenti 
negli spots down-regolati. Un’analisi in silico, ha consentito di 
identificare tra queste, 26 putativi targets del miR-494, di cui 9 sono 
stati da noi selezionati per l’analisi funzionale. Con saggi di attività 
della luciferasi abbiamo dimostrato che quattro di essi (hnRNPA3, 
PDIA3, RAD23B, SYNCRIP/hnRNPQ) presentano siti di legame 
funzionali per il miR-494. Abbiamo anche dimostrato che 
l’espressione di hnRNPA3, PDIA3, RAD23B, SYNCRIP è diminuita 
oppure aumentata in condizioni di iper-espressione o inibizione del 
miR-494, rispettivamente. La ridotta espressione di tali proteine è 
stata anche ritrovata in altri modelli di senescenza cellulare. Abbiamo 
anche dimostrato che il silenziamento di hnRNPA3 o RAD23B in 
cellule giovani IMR90 induce un fenotipo senescente simile a quello 
indotto dall’over-espressione del miR-494, e mediato dall’attivazione 
del pathway di p53. Infine, altri risultati hanno dimostrato che il 
fenotipo senescente indotto dal miR-494 è prevenuto se nelle cellule è 
stato introdotto il gene hnRNPA3 oppure RAD23B. 
 
L’altro aspetto del progetto ha riguardato l’analisi comparativa del 
profilo proteico sia della senescenza replicativa che della senescenza 
precoce indotta dallo stress ossidativo. Abbiamo evidenziato 20 spot 
proteici comuni alle due condizioni, differenzialmente rappresentati (3 
up- e  17 down-regolati) in cui con la spettrometria di massa sono 
state identificate 25 componenti proteiche diverse. Per verificare se la 
down-regolazione di tali geni è basata su meccanismi di regolazione 
che agiscono a livello trascrizionale, i livelli degli mRNA delle 25 
proteine sono stati analizzati nei due modelli di senescenza. Tra 
questi, 10 geni che presentavano almeno 2 volte di diminuzione di 
mRNAs nelle 2 condizioni, sono stati ulteriormente analizzati.  Per 
corredare poi di significato funzionale la down-regolazione di queste 
proteine, abbiamo silenziato individualmente l’espressione di questi 
 
 
 10 geni con siRNA specifici nelle cellule IMR90 giovani. I risultati 
dimostrano che il silenziamento dei geni LEPRE1, LIMA1/EPLIN, 
MAGOHA e MAGOHB, induce un fenotipo senescente con presenza 
di marcatori specifici e mediato, nel caso di MAGOHA e MAGOHB, 
dall’attivazione del pathway di p53.  
Abbiamo successivamente analizzato sia ai livelli proteici che di 
mRNA in: i) cellule IMR90 senescenti dopo danno al DNA; ii) in 
cellule WI38 senescenti per accorciamento dei telomeri, o stress 
ossidativo;  iii) fibroblasti provenienti da donatori di età diversa 
compresa tra 21 e 94 anni. I risultati hanno dimostrato che nelle 
cellule senescenti, sia in vitro che in vivo, i livelli delle proteine e 
quelli dei rispettivi mRNA sono  diminuiti. 
Infine, poiché è noto che modifiche selettive degli istoni, in particolare 
la metilazione delle lisine dell’istone H3, giocano un ruolo cruciale 
nei meccanismi di regolazione dell’espressione genica a livello 
epigenetico, abbiamo verificato lo stato di metilazione dell’istone H3 
dei promotori dei geni LEPRE1, LIMA1/EPLIN, MAGOHA e 
MAGOHB in condizioni di senescenza. A tale scopo abbiamo 
effettuato esperimenti di immunoprecitazione della cromatina 
utilizzando anticorpi specifici per il marcatore repressivo H3K27me3 
oppure per il marcatore attivatorio H3K4me3. I risultati dimostrano 
che l’espressione ridotta di tali geni nella senescenza è associata ad 
incremento della quantità di marcatore repressivo H3K27me3 ed in 
quasi tutti i casi a diminuzione del marcatore attivatorio H3K4me3. 
In conclusione i dati ottenuti con l’approccio di proteomica 
differenziale hanno consentito di  identificare nuovi geni (hnRNPA3 e 
RAD23B LEPRE1, LIMA1/EPLIN, MAGOHA, MAGOHB) che 
hanno un ruolo causativo nella comparsa del fenotipo senescente.  
Tali risultati se da un lato contribuiscono all’approfondimento dei 
meccanismi molecolari della senescenza, dall’altro pongono le basi 
per considerare tali geni possibili marcatori dell’invecchiamento e 
delle patologie età-correlate, nonchè candidati per sviluppare strategie 
terapeutiche per la manipolazione in vivo della senescenza cellulare. 
 
 
 
 
 
 Summary 
 
Normal cells do not replicate indefinitely, rather after a certain 
number of divisions, they enter into a state of permanent arrest of 
proliferation defined cellular senescence. 
Cellular senescence is accompanied by a reprogramming of gene 
expression profile, resulting in changes of the regulatory mechanisms 
that act at both transcriptional and post-trascriptional as well as at 
epigenetic level. 
MicroRNAs (miRs) are small non-coding RNAs that play a 
fundamental role in the negative regulation of gene expression at post-
transcriptional level. They recognize sequences in the 3'UTR and 
block the translation or determine the degradation of messenger 
RNAs. 
In the laboratory had previously been identified 24 miRs (SAmiRs) 
up- or down-regulated in cellular senescence of primary fibroblasts 
IMR90. Functional studies on SAmiRs up-regulated demonstrated that 
5 of them are able to induce premature senescence phenotype when 
over-expressed in young cells, in particular, the miR-494 elicited the 
most robust senescent phenotype. 
Our studies have pursued two main objectives: 
i) to study the regulatory pathways in which is involved the miR-494 
through the identification of its molecular targets; 
ii) to identify novel common mediators/effectors of cellular 
senescence induced by telomere shortening or caused by oxidative 
stress. 
For both aims, we choose a high-throughput proteomic approach 
using the technology of 2D-DIGE (Two Dimensional-Difference Gel 
Electrophoresis) coupled to Mass Spectrometry (LC-MS / MS). 
In the first objective, to identify possible targets of miR-494, we 
monitored with 2D-DIGE changes at the protein level consequent to 
its overexpression in cells IMR90 young, considering the inverse 
relationship between levels of miRs and protein levels of their targets. 
The 2D-DIGE analysis allowed us to consider about 1500 protein 
spots present in both of the two conditions. Among these, 102 protein 
spots (38 up- and 64 down-regulated) were differentially represented 
 
 
 in the cells transfected with miR-494, compared with control cells 
transfected with miR-scrable. Mass Spectrometry analysis identified 
172 different protein species, of which 121 present in the spots down-
regulated. In silico analysis, allowed the identification among these of 
26 putative targets of miR-494, 9 of which have been selected by us 
for functional analysis. By using luciferase assays, we showed that 
four of them (hnRNPA3, PDIA3, RAD23B, SYNCRIP / hnRNPQ) 
contain functional binding sites for miR-494. We also showed that the 
expression of hnRNPA3, PDIA3, RAD23B, SYNCRIP decreased or 
increased in conditions of over-expression or inhibition of miR-494, 
respectively. The reduced expression of these proteins has also been 
found in other models of cellular senescence. We also showed that 
silencing hnRNPA3 or RAD23B in young IMR90 cells induces a 
senescent phenotype similar to that induced by the over-expression of 
miR-494, and mediated by the activation of the p53 pathway. Finally, 
other results have shown that the senescent phenotype induced by 
miR-494 is prevented if in the cells was introduced hnRNPA3 or 
RAD23B genes. 
 
The other aspect of the project involved the comparative analysis of 
the protein profile occurring both in replicative senescence and 
premature senescence induced by oxidative stress. We showed that 20 
protein spots common to both conditions are differentially represented 
(3 up- and 17 down-regulated) and in these the Mass Spectrometry 
identified 25 different protein components. To check whether the 
down-regulation of these genes is based on regulatory mechanisms 
that act at the transcriptional level, the levels of mRNAs of 25 proteins 
were analyzed in the above reported models of senescence. Among 
them, 10 genes that had at least 2 times decrease of mRNAs in both 
conditions, were further analyzed. Then, to study the functional 
significance of the down-regulation of these proteins, we individually 
silenced the expression of these 10 genes using specific siRNA in 
young IMR90 cells. The results show that silencing of LEPRE1, 
LIMA1/EPLIN, MAGOHA and MAGOHB genes, induces a 
senescent phenotype with the presence of specific markers and 
mediated, in the case of MAGOHA and MAGOHB, by the activation 
 
 
 of the p53 pathway. 
We then looked at both protein and mRNA levels in: i) IMR90 
senescent cells after DNA damage; ii) WI38 senescent cells caused 
either by telomere shortening or oxidative stress; iii) fibroblasts from 
donors of different ages between 21 and 94 years. The results showed 
that in senescent cells, both in vitro and in vivo, the levels of the 
proteins and those of the respective mRNAs are decreased. 
Finally, since it is known that selective histone modifications, in 
particular the methylation of histone H3 lysine, play a crucial role in 
the mechanisms of gene expression regulation at epigenetic level, we 
verified the methylation status of histone H3 in the promoter genes of 
LEPRE1, LIMA1/EPLIN, MAGOHA and MAGOHB during 
senescence. For this purpose, we performed chromatin 
immunoprecipitation experiments using antibodies specific for the 
repressive H3K27me3 marker or for the active H3K4me3 marker. The 
results demonstrate that the reduced expression of these genes in 
senescence is associated with increase in the amount of repressive 
H3K27me3 and in almost all cases to decrease of active H3K4me3. 
In conclusion, the data obtained with the approach of differential 
proteomics have identified novel genes (hnRNPA3 and RAD23B 
LEPRE1, LIMA1/EPLIN, MAGOHA, and MAGOHB) that have a 
causative role in the appearance of the senescent phenotype. 
These results on one hand contribute to gain a deeper knowledge of 
the molecular mechanisms involved in senescence and on the other 
creates the basis for considering these genes as possible markers of 
aging and age-related diseases, as well as candidates for developing 
therapeutic strategies for the manipulation of in vivo cellular 
senescence.  
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Introduction 
 
1. Introduction 
1.1 Cellular senescence: causes and markers 
 
Cellular senescence was described for the first time in 1961 by 
Hayflick and Moorhead as an inevitable and irreversible cell-cycle 
arrest after a series of passages in culture of normal fibroblasts (1). In 
fact, the life span of primary normal cells is determined by a limited 
number of divisions, called the Hayflick limit, after which cells arrest, 
usually in the G1 phase, and no longer respond to growth factors. This 
phenomenon also known as “replicative senescence”, is causally 
linked to telomere attrition. In normal human fibroblasts telomeres 
shorten progressively at each cell division and when they reach a 
critically short length, the cell perceives this as a persistent DNA 
damage, a primary cause of the senescence onset.  
Initially, cellular senescence was considered an artefact of culture and 
its contribution to organismal aging was only hypothesized (1). 
Recent studies demonstrate that replicative senescence also occurs in 
vivo and in other cell types including keratinocytes, endothelial cells 
and lymphocytes. Furthermore, different stressors have also been 
demonstrated to induce prematurely a similar phenotype of 
senescence, called premature senescence. Thus, more generally, 
senescence can be considered as a state of stable cell cycle arrest in 
response to diverse types of stress (2). These stressors can be intrinsic 
or extrinsic and include activated oncogenes such as mutated forms of 
RAS or BRAF, loss of tumor suppressors genes, i.e. PTEN, NF1, 
increased oxidative stress, ionizing/ultraviolet radiations (2-6). Most 
of these stimuli can directly or indirectly induce DNA damages that in 
turn trigger a DNA damage response (DDR) (Figure 1) (7). When 
DDR becomes persistent, the cells activate prematurely the 
senescence program. Persistent DDR signaling, initiated both at 
telomeric and non-telomeric sites, drives also senescence in vivo (8), 
whose importance is now recognized in aging and age-related 
pathologies as well as in tumor suppressor mechanism (3,9). 
Senescent cells show a distinct morphology with an enlarged and 
flattened shape, prominent nucleoli and citoplasmic granules, and also 
produce specific markers, that include overproduction of Reactive 
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Oxygen Species (ROS), formation of heterochromatic foci (SAHF) 
derived from reorganization of chromatin, presence of DNA damage 
foci (SDF) and promyelocytic leukemia protein nuclear bodies (PML 
NBs), increased lysosomal β-galactosidase activity at pH 6 
(Senescence-Associated β-gal, SA-β-gal), same of which are used to 
detect senescent cells also in vivo (10).  
Furthermore, senescent cells acquire a specific secretory phenotype 
called SASP (Senescence-Associated Secretory Phenotype) or SMS 
(Senescence-Messaging Secretome) enriched for pro-inflammatory 
cytokines, chemokines, growth factors, and metalloproteases that 
could affect positively or negatively the tissue homeostasis. Among 
these, certain cytokines and chemokines, in particular interleukin-6 
(IL-6) and interleukin 8 (IL8) as well as its receptors appear to 
reinforce the proliferative arrest, promote immune clearance of 
damaged cells, communicate to the surrounding cells the state of 
senescence, thus influencing positively the behavior of adjacent cells. 
Paradoxically, persistent activity SASP factors can have negative 
effects by causing chronic inflammation, disturbing tissue architecture 
and stimulating phenotypes associated with both cancer initiation and 
growth (11). 
Another characteristic of senescent cells is the altered reactivity to 
apoptotic stimuli. Indeed, many senescent cells are resistant to 
apoptotic signals, related to the increase of the anti-apoptotic protein 
bcl2 and reduction of caspase-3. This resistance may explain why 
senescent cells accumulate in tissues with age, although it has recently 
been shown that there is an important mechanism for the removal of 
senescent cells (clearance) by the immune system (12). 
All the above characteristics are tightly associated with a global 
change in the gene expression profiles (8,13). In fact, senescent cells 
up-regulate numerous genes involved in cell cycle arrest as well as in 
the production of SASPs and down-regulate genes controlling cell 
cycle progression. Modifications of gene expression are governed at 
transcriptional, post-transcriptional and epigenetic levels.  
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Figure 1: Causes and hallmarks of  cellular senescence. 
Cellular senescence is a permanent cell cycle arrest triggered by different type of 
stresses, that result in DNA damage, which in turn triggers a DNA damage response 
(DDR). When DDR becomes persistent, cells activate the senescence program. 
The senescent cells acquire specific hallmarks of senescence such as: morphological 
changes, absence of duplications, secretion of various molecules (SASP), positive 
staining for Senescence-Associated beta-Galactosidase activity (SA-β-Gal), 
appearance of Senescence-Associated heterochromatin foci (SAHF) and 
Senescence-Associated DNA-damage foci (SDF). All these marks are supported by 
a global change of gene expression. 
Figure 1 
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1.2 Cellular senescence: regulation of gene expression  
 
Modification of gene expression is a major determinant for the 
induction of the senescence program, in which are involved specific 
alterations of transcriptional and post-transcriptional events as well as 
epigenetic regulatory mechanisms (14-18) 
This transcriptional program involves modification of cell cycle-
related genes with down-regulation of genes promoting cell cycle 
along with up-regulation of p21 and p16INK4a genes governing cell 
arrest and many others genes with other functions including some 
with enzymatic activity (i.e. β-galactosidase, matrix-remodeling 
proteases) as well as inflammatory chemokines, cytokines and growth 
factors (19).  
A key regulatory factor involved in transcriptional regulation of genes 
implicated in cell cycle arrest such as p21, GADD45A, RPRM (20) is 
p53 that will be discussed later (in the section 1.3).  
The induction of cell cycle arrest is also dependent on the 
Retinoblastoma (Rb) protein family that contains the three members 
Rb, p107 and p130. Among these, Chicas at al. (21) demonstrated that 
Rb is the main factor for determining the permanent cell cycle arrest, 
unique to senescence, by inhibition of E2F-dependent transcription of 
a subset genes specifically involved in DNA replication. A recent 
study of Vernier et al. (22) reported that in senescent cells Rb/E2F 
complexes localize in PML nuclear bodies along with heterochromatin 
protein 1 (HP1) and Rb phosphatase PP1α (protein phosphatase 1α). 
Since HP1 has a causal role in chromatin architecture changes, and 
PP1α contributes to the hypophosphorilated-Rb status, the proposed 
model is that PML NBs could be the site of “nucleation” or initiation 
of the heterochromatization of E2F target genes.  
Given that senescent cells secrete numerous soluble factors known as 
SASP, a specific transcriptional program inducing expression of these 
genes is activated by the transcription factors NF-kB and C/EBPβ 
(11). NF-kB contributes to the senescence by reinforcing growth arrest 
and activating IL6 and IL8 gene transcription. These genes are also 
regulated by C/EBPβ  that is manly required for cellular senescence 
induced by oncogenic stress. Moreover, the activity of NF-kB and 
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C/EBPβ is regulated by the IL1 signaling (also known as 
inflammasomes) (23,11), thus creating a positive feedback loop 
that contributes to the establishment of the senescence program.  
Another mechanism of gene regulation that acts at post-transcriptional 
level involves microRNAs (miRNAs)  (24).  miRNAs are a class of 
short (around 22 nucleotides) non-coding RNA molecules that behave 
as negative modulators of gene expression. miRNAs recognize 
complementary sequences that are generally localized in the regions 
of the 3' untranslated (3'UTRs) of target mRNAs and function with a 
sequence-specific silencing mechanism (25). 
Most of the genes for miRNAs are transcribed from RNA polymerase 
II (Pol II) as long precursors transcripts that form a hairpin stem loop 
structure necessary for the processing into pre-miRNAs by a 
multiproteic complex, called “Microprocessor” consisting of Drosha 
(RNase III endonuclease) and DiGeorge syndrome critical region 8 
(DGCR8) (26). pre-miRNAs are 60- to 70-nucleotide long and are 
then transported to the cytoplasm by Exportin 5 where they are further 
processed to duplex RNAs of about 22 nucleotides 
(miRNA:miRNA*) by Dicer. The mature miRNA originated from 
Dicer activity is guided to the target mRNAs by base-pairing 
interactions, after its incorporation into the RNA-induced silencing 
complex (RISC). The mechanisms proposed for miRNA-mediated 
activity are three: i) miRISC could mediate the repression of 
translation by competition between Ago2 and eiF4E for cap binding, 
ii) miRISC could stimulate the deadenylation of the mRNA tail that 
causes degradation of the mRNAs, iii) the miRISC could also block 
association of ribosomal subunits (26). 
Given that each single miRNA could targets many transcripts (up to 
hundreds), miRNAs might influence a large variety of cellular 
processes (27). Recent findings, also obtained in our laboratory (28), 
show that miRNAs are regulated during cellular senescence and, in 
turn, are able to trigger senescence (29–32) by affecting specific genes 
involved in DDR, telomere protection/attrition, homeostatic processes, 
as well as genes involved in gene expression regulation, thereby 
affecting transcriptional, post-transcriptional and epigenetic changes 
(33).  We have reported that 5 miRNAs, (miR-210, miR-376a*, miR-
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486-5p, miR-494, miR-542-5p), which are up-regulated during the 
senescence process of primary human diploid IMR90 fibroblasts, 
activated a premature senescence program when overexpressed in 
young cells. Among them, miR-494 elicited the most robust effects by 
inducing features such as reduced cell proliferation, induction of SA-
β-gal, SAHFs, DNA damage, SDFs, and reactive oxygen species 
(ROS) accumulation (28). Another miR that resulted up-regulated in 
these studies is miR-210.  Regarding miR-210, a recent paper 
demonstrated that its role in senescence is also linked to the direct 
repression of Polycomb group protein (PcG) members that are 
involved in the inactivation of the p16INK4aencoding gene (34). 
The above results exemplify another important mechanism of gene 
expression regulation: the epigenetic modifications that are also 
fundamental for the induction/establishment of cellular senescence 
(33). Among these, selective histone modifications play a critical role 
in the patterns of gene expression associated to senescence. In fact, the 
formation of senescence-associated heterochromatin foci (SAHF) 
responsible for E2F target genes silencing (35) or the activation of the 
INK4A-ARF locus that encodes p16INK4a (36, 37) involves 
modifications of the methylation status of the lysines within the H3 
histone. SAHFs, indeed, are characterized by H3 bearing 
trimethylated Lys9 (H3K9me3) that acts as a repressive mark, 
whereas the INK4A-ARF locus displays a decreasing level of 
trimethylated Lys27 (H3K27me3) behaving as a repressive mark. Of 
note, the miR-210 post-transcriptional regulation of PcG proteins 
establishes a cross-talk in senescence between microRNAs and 
epigenetic regulators of transcription.  
Very recently, genome-wide studies have associated lamin B1-
dependent chromatin reorganization upon senescence not only to 
SAHF formation but also to gene expression regulation. In fact, local 
increase of H3K27me3 facilitated repression of a subset of genes 
involved in cell proliferation (38), whereas depletion of H3K4me3 and 
H3K27me3 paralleled with down- and up-regulation of proliferating 
and SASP genes, respectively (39). An increase of repressive marks 
and a decrease of active marks were also observed during oncogene-
induced senescence (40). 
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1.3 Cellular senescence: molecular pathways  
 
The molecular determinants that establish the enter in senescence are 
not fully understand. However, telomere shortening-related replicative 
senescence, occurring in vivo and in vitro, and premature senescence 
are governed by a persistent DNA damage response (DDR) (41,42). In 
general, this event engages various cellular signalling cascades that 
ultimately activate p53 or p16INK4a, or both (43,44) (Figure 2). Very 
interestingly the levels of both proteins, especially those of p16INK4a, 
correlate with chronological ages in humans and in mice. (33). The 
relative contribution of these pathways is dependent on cell type, and 
the types of insults. (44) 
p53, also known as tumor protein 53 (TP53), is a transcription factor 
that regulates a variety of cellular responses, including cell cycle 
arrest and DNA repair as well as apoptosis, metabolism and 
senescence (45). It plays the role of tumor suppressor and is 
recognized as "the guardian of the genome" referring to his function in 
maintaining the genome stability by preventing/repairing mutations 
that could initiate tumorigenic events.  
In normal cells, p53 is usually inactive, bound to MDM2 protein that 
promotes its degradations working like an ubiquitin ligase. After 
initial events of DNA damage, cells activate a p53-dependent transient 
cell cycle arrest to induce repair of DNA. When the DNA damage is 
irreparable, in particular involves DNA double strand breaks (DSBs), 
the arrested state becomes permanent (senescence). The DSBs are 
detected by the MRN (MRE11, RAD50, NBS1) complex that 
promotes auto-phosphorylation and activation of ATR (Ataxia 
Telangiectasia and Rad3 related) or ATM (Ataxia Telangiectasia 
Mutated) leading to the subsequent phosphorylation of specific 
ATR/ATM substrates. One of these is the histone variant H2AX that 
in phosphorylated state (γ-H2AX) accumulates to sites of DNA 
damage and induces changes in local chromatin structure. These γ-
H2AX foci presumably attract specific repair factors, including ATM 
its self. In this platform the protein 53BP1 is responsible for the 
recruitment of p53 that undergoes stabilization and ATM-dependent 
phosphorylation at serine 15. In addition, p53 can also be 
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phosphorylated by the checkpoint kinase CHK2 that along with CHK1 
is activated by different types of DNA damage (46).  
Once activate, p53 induces transcription of many genes (20,47) 
including p21 and PML (promyelocytic leukemia) which are also 
recognized as markers of senescence. The p21 gene encodes a potent 
cyclin-dependent kinase (CDK) inhibitor, called p21 (also known as 
WAF1) that generally arrests cell-growth in G1 phase. Indeed p21 
inhibits the activity of cyclin-CDK2 or CDK4 complexes, with a 
subsequent block of E2F- and PCNA-dependent cell cycle 
progression. PML is the major structural component of PML nuclear 
bodies that are increased during senescence (48). PML and p53 
activity are interlinked because p53 activates the transcription of PML 
that in turn interacts with both p53 and MDM2. Thus, beside MDM2, 
the p53 activity is under the control of the PML protein, which 
operates a positive feedback on the p53-dependent pathways of 
senescence (48). Furthermore, PML by recruiting the complex 
pRb/E2F, also contributes to cellular senescence induced by 
p16INK4a/Rb-dependent pathways (22).  
Of note, cellular senescence could be also activated by p53-
independent mechanisms as demonstrated for the inactivation of VHL 
tumor suppressor (49) or inactivation of the oncogenic protein Sk2p in 
the context of both PTEN or ARF loss (50) as well as for programmed 
senescence occurring during development (51, 52). Additionally, it 
has been also demonstrated that senescence can be induced through a 
DDR-independent manner. For example BRAF (V600E) induces an 
unusual senescence through a metabolic effector pathway. BRAF 
(V600E) activates PDH (pyruvate dehydrogenase) by inducing PDP2 
and inhibiting PDK1 expression, promoting a shift from glycolysis to 
oxidative phosphorylation that creates senescence-inducing redox 
stress associated to the release of SASP factors (53).  
p16INK4a/pRb pathway is mainly activated in premature senescence 
and is regarded as a principal marker of senescent cells in vivo. 
p16INK4a is encoded by the INK4/ARF locus that also encoded for 
ARF, an upstream positive regulator of p53 (54). p16INK4a by 
inhibiting the activity of CDK4 and CDK6, prevents the 
phosphorylation of Rb,  thus blocking the release of E2F required for 
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transcription of genes promoting proliferation (54). On the contrary, 
the hyperphosphorylation of Rb allows the progression of the cell 
cycle. Thus, both pathways of p16INK4a and p53/p21converge into 
retinoblastoma protein and by repressing its phosphorylation prevent 
the E2F activity, thereby leading to cell cycle arrest. 
Several studies demonstrated that p16INK4a has also other functions. 
For example, up-regulation of p16INK4a in human mammary epithelial 
cells mediates silencing of the hTERT promoter through histone 3 
lysine 27 trimethylation (55).  
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Figure 2: Pathways involved in cellular senescence.  
The senescence-inducing stresses are able to engage various cellular signalling 
cascades that, depending on the type of stress, involve p53/p21 or p16INK4a, or both 
pathways. They, through activation of cell cycle inhibitors, lead to phosphorylation of 
tumor suppressor pRb. When pRb becomes hyper-phosphorylated, its binding to E2F 
is inhibited and this allows the transcription of several E2F-target genes, most of 
which are involved in the G1/S transition phase. 
 
Figure 2 
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1.4 Cellular senescence: biological impact  
 
Numerous studies in the last 10 years have demonstrated that cellular 
senescence occurs in vivo and has both physiological and pathological 
consequences on the functionality of the organism (12,56).  
It is now largely accepted that cellular senescence represents a failsafe 
program activated in response to potential oncogenic events, thus 
reducing the risk of neoplastic transformation. In fact, replicative 
senescence imposes a self-limiting proliferative capacity when 
genomic damages, such as telomere shortening, could initiate/fuel 
tumorigenesis and premature senescence arrests the propagation of 
cells with non-telomeric irreparable damage DNA or with aberrant 
activation of oncogenes caused by mutations (i.e. RAS, RAF) referred 
as oncogene-induced senescence (OIS), as well as with loss of tumor 
suppressors (i.e. PTEN, VHL). According to this, in human nevi that 
frequently harbor mutations in BRAF, cells possess positive markers 
for senescence such as overexpression of p16INK4a (57) and in PTEN-
deficient tumorigenesis a p53-dependent senescence has been also 
described (58). 
In addition to its function as tumor suppressor, another positive role of 
cellular senescence in vivo has been shown in tissue damages of 
different tissues. In particular, in a mouse model of liver fibrosis has 
been demonstrated that the senescence of fibrogenic myofibroblasts 
by producing SASPs containing extracellular matrix-degrading 
enzymes as well as cytokines, and by recruiting cells for immune 
surveillance, could limit fibrosis during tissue repair (12). Similarly, 
in the skin wound healing, senescence could represent a mechanism 
for controlling fibrinogenesis (56).  
Furthermore, very recently has been demonstrated that cellular 
senescence also occurs during the embryonic development. In this 
context, it plays an important physiological role associated with 
instructing tissue growth and organ patterning (51, 52). The 
embryonic senescent cells do not activate DDR and p53 or p16INK4, 
but display some features i.e. production of SASP and induction of 
p21 dependent on SMAD and FOXO transcription factors (52). 
Although these beneficial roles, cellular senescence is now considered 
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a crucial contributor to organismal aging and age-related diseases. In 
this context, in vivo accumulation of senescent cells with age not only 
impacts negatively on the functionality of tissues but also limits tissue 
renewal as a consequence of adult stem cells senescence.  
Although its specific relevance in vivo needs further investigations, 
the activities of SASP seem to be key contributors for both 
physiological and pathological consequences of senescence in the 
organism. Transient SASP components such as IL6 and IL8 can 
indeed reinforce the senescence in an autocrine fashion as well as 
recruit cells of immune system to eliminate senescent cells, thus 
contributing positively on the senescence-tumor suppressor activity in 
the organism. On the contrary, a persistent SASP activity, in particular 
due to IL1, can act in a paracrine fashion by promoting both chronic 
inflammation, that has a predominant role in various age-related 
pathologies, and senescence in neighbouring cells that could disturb 
architecture and functionality of tissues. These conditions can also 
stimulate events that contribute to a pro-tumorigenic state in 
surrounding cells (11,59).  
It is now generally accepted that senescent cells accumulate during the 
life of the organism and contribute to aging and age-related diseases.  
Recently, the van Deursen group has demonstrated that inducibile 
elimination of p16INK4a-positive senescent cells in BubR1 progeroid 
mouse model delayed the onset of age-related phenotypes in several 
tissues such as eye, adipose and skeletal. They showed that 
elimination of  p16INK4a-positive cells also attenuated the progression 
of already established age-related disorders, thus suggesting that 
cellular senescence may have a causal role in age-related tissue 
impairment (19).  
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1.5 Scientific hypothesis and aim of the work 
 
Cellular senescence is tightly associated with a global change in the 
gene expression profile. Modification of gene expression involves 
specific alterations of transcriptional and post-transcriptional events as 
well as epigenetic regulatory mechanism.  
The major contributors of post-transcriptional regulation of gene 
expression are microRNAs (miRNAs). Recent findings, obtained also 
in our laboratory, show that miRNAs are regulated during cellular 
senescence and, in turn, are able to trigger senescent phenotype. We 
reported that ectopic expression of 5 miRs which are up-regulated 
during senescence of human diploid IMR90 fibroblasts, promoted a 
premature senescent phenotype. Among them, miR-494 elicited the 
most robust effects, including reduced of cell proliferation, induction 
of SA-β−gal activity, appearance of SAHFs, DNA damage,  SDFs and 
accumulation of reactive oxygen species (ROS). 
Specific modifications of selective histones play a critical role in 
epigenetic-associated regulatory mechanisms. Of note, the 
methylation status of the lysines within the H3 histone particularly 
contributes to the stability of the senescent phenotype, as exemplified 
by the formation of senescence-associated heterocromatin foci 
(SAHF) that are responsible for E2F target genes silencing or INK4A-
ARF locus activation, both essential for the senescence onset.  
In this study we used a proteomic approach, particularly 2D-DIGE 
coupled to Mass Spectrometry analysis, to follow two main 
objectives: 
• To identify novel direct targets of miR-494 in human diploid 
IMR90 fibroblasts that could play a crucial role in the 
induction of the senescence program and to investigate the 
functional effects after their manipulations in young and 
senescent cells. 
• To identify novel genes acting as common mediators of the 
senescence induced either by telomere shortening or by 
oxidative stress in IMR90 cells and to study the effects of their 
manipulation, the epigenetic regulation of their expression as 
well as the relevance in vivo of these findings. 
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2. Materials and Methods  
2.1 Cellular cultures and reagents  
 
Normal human primary fibroblasts IMR90 were obtained from Coriell 
Institutes for Medical Research  (CCR; New Jersey, USA). Cells were 
cultured in Dulbecco’s modiﬁed Eagle’s medium (DMEM) 
(Invitrogen, Groningen, The Netherlands) supplemented with 10% v/v 
fetal bovine serum and 1% penicillin/streptomycin (Invitrogen). WI38 
at passage 11 (p11) or 15 (p15) were kindly provided by Fabrizio 
d’Adda di Fagagna (Istituto di Oncologia Molecolare, Fondazione 
Italiana per la Ricerca sul Cancro, Milan, Italy) and cultured in 
modified Eagle’s medium supplemented with 10% FBS, 10 mM non-
essential amino acids, and 1 mM sodium pyruvate (Invitrogen) until 
passage 23 (p23). The population doubling level (PDL) was calculated 
by using the formula PDL=log(nh/ni)/log2, where ni is the initial 
number of cells and nh is the ﬁnal number of cells at each passage. To 
induce premature senescence, IMR90 at PDL34 or WI38 cells at 
PDL30 were treated with 100 µM diethylmaleate (DEM) (Sigma-
Aldrich) for ten days (28).  
Primary fibroblast cell lines from healthy donors of different ages 
were obtained from CCR. Cells lines from young donors were 
AG09309 (21 years, skin, PDL12), AG10803 (22 years, skin, 
PDL11.7) and AG09319 (24 years, gingival, PDL9) and were grown 
in Essential Medium with Earl’s salts/non-essential amino acids (both 
from Lonza, Switzerland) supplemented with 10% or 15% v/v fetal 
bovine serum (according to CCR’s instructions) and 1% 
penicillin/streptomycin (Invitrogen), at 37 °C, in a 5% CO2-
humidiﬁed atmosphere. Cells lines from old donors were AG05247 
(87 years, skin, PDL15), AG10884 (87 years, skin, PDL7), AG04064 
(92 years, skin, PDL16.41), AG09602 (92 years, skin, PDL5.48), 
AG08433 (94 years, skin, PDL15.52) (60, 61). These were grown in 
Eagle’s Minimum Essential Medium (MEM) containing Hank’s BSS, 
26 mM Hepes (Lonza) and supplemented with 15% v/v fetal bovine 
serum and 1% penicillin/streptomycin (Invitrogen), at 37 °C, in a 5% 
CO2-humidiﬁed atmosphere. 
Transfections of young IMR90 cells (PDL33) with synthetic premiRs 
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(100 nM; Invitrogen) and miRcury LNA microRNA inhibitors (100 
nM; Exiqon, Vedbaek, Denmark) were performed by electroporation 
with a Microporator MP100 (Euro-Clone, Milan, Italy), as described 
previously (28). Transfections of small interfering RNAs (siRNAs; 25 
or 50 nM; Qiagen, Hilden, Germany) were performed using 
Lipofectamine RNAiMAX transfection reagent (Invitrogen) with the 
reverse protocol, following manufacturer’s suggestions with the 
reverse protocol, according to manufacturer’s instructions. All the 
plasmids bearing 3’-UTR fragments were transfected in IMR90 cells 
with Lipofectamine 2000 (Invitrogen) in 48-well plates (20,000 
cells/well), according to manufacturer’s instructions.  
 
2.2 2D-DIGE coupled to Mass Spectrometry analysis 
 
In our studies, we have analyzed the differential protein expression by 
2D-DIGE in: 
• IMR90 cells (PDL33) transfected with premiR-494 and 
compared to premiR-scramble (control). 
•  two conditions of senescence, IMR90 at PDL58 and IMR90-
DEM, compared to young IMR90 cells. 
For both experiments, total proteins, from three independent 
biological replicates of each condition, were extracted with UTC 
solution (7 M urea, 2 M thiourea, and 4% w/v 3-[(3-
cholamidopropyl)dimethylammonium]-1-propane sulfonate). Lysates 
were precipitated in 8:1 v/v acetone/methanol for 16 h, at −20 °C, and 
centrifugated at 16,000 × g for 30 min, at 4 °C. Protein pellets were 
dissolved in UTC solution and samples (30 µg in a final volume of 10 
µL) were labeled with the appropriate CyDye (240 pmol of Cy2, Cy3, 
or Cy5) according to the DIGE minimal labeling protocol (GE 
Healthcare, Milan, Italy) by implementation of a dye-swapping 
strategy (62). An equal mixture of all three samples of each biological 
replicate was labeled with Cy2 as internal standard during gel 
electrophoresis to allow gel-to-gel matching and in-gel analyses of 
relative protein spot intensities. Three sample mixtures, made of 
appropriate Cy3- and Cy5-labeled pairs and a Cy2-labeled control, 
were supplemented with UTC solution containing 130 mM DTT, 2% 
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immobilized pH gradient (IPG) buffer (pH 3–10 NL), and 2.8% 
DeStreak reagent (GE Healthcare, Little Chalfont, UK), and used for 
passive hydration of immobilized pH gradient (IPG) strips (24 cm) to 
run the isoelectric focusing on IPGphor II apparatus (GE Healthcare). 
After the first dimension, the strips were equilibrated and transferred 
into 12% polyacrylamide gels to perform the second dimension. SDS-
PAGE was performed on a DALT II electrophoresis unit (GE 
Healthcare) at 1 W/gel for 16 h. Gels were scanned on a Typhoon 
9400 variable mode imager (GE Healthcare), with the indicated 
excitation/emission wavelengths for Cy2 (488/520 nm), Cy3 (532/580 
nm), and Cy5 (633/670 nm). 2D-DIGE images were acquired in the 
Image Quant software (GE Healthcare) and analyzed by using the 
DeCyder 6.0 software (GE Healthcare). A DeCyder differential in-gel-
analysis module was used for spot detection and pairwise comparison 
of each sample (Cy3 and Cy5) to the Cy2 mixed standard present in 
each gel. The DeCyder biological variation analysis module was then 
used to simultaneously match all of the protein-spot maps from the 
gels, and to calculate average abundance ratios and p values across the 
triplicate sets of samples (Student’s t-test). Only protein spots with a 
value of p < 0.05 were investigated further.   
For preparative protein separations, 600 µg of unlabeled total proteins 
from pooled IMR90 at PDL34, IMR90 at PDL58 and IMR90-DEM 
extracts were used for passive hydration of 24 cm strips for the first 
gel dimension (pH 3–10 NL IPG strips, GE Healthcare). The first and 
second-dimension runs were carried out as described above. After 2-
DE, gels were fixed and stained with SyproRuby fluorescent stain 
(Invitrogen-Life Technologies Italia, Monza, Italy). Finally, spots 
were matched with those of master gel from the analytical step in the 
biological variation analysis module of DeCyder software to generate 
a pick list for spot picking by a robotic picker (Ettan spot picker, GE 
Healthcare).  
Afterwards, the spots were excised from the relative preparative gel 
and were processed for protein identification by Mass Spectrometry 
analysis (63). This analysis was performed in collaboration with the 
laboratory of Prof. Andrea Scaloni (Laboratorio di Proteomica e 
Spettrometria di Massa, ISPAAM, Consiglio Nazionale delle 
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Ricerche, Napoli, Italia). 
 
2.3 Bioinformatic analysis 
 
For the identification of miR-494 putative targets, 5 different software 
algorithms were used, namely TargetScan 6.2 
(http://www.targetscan.org), miRanda (http://www.microrna.org), 
miRDB (http://mirdb.org), PITA (http://genie.weizmann.ac.il), and 
RNA hybrid (http://bibiserv.techfak.uni-
bielefeld.de/rnahybrid/welcome.html). The intersection of >3 
programs resulted in a list of 26 genes as potential targets for miR-494 
(Table 1). 
 
2.4 Constructs and reporter assay 
 
The 3’-UTR fragments containing miR-494 binding sites of candidate 
genes were amplified by PCR using human IMR90 DNA with primer 
pairs containing XbaI and BamH1 sites (Table MM1). The PCR 
products were cloned into the pGL3-control vector, downstream from 
the Firefly luciferase 3’-UTR (Promega, Madison, WI, USA). The 
orientation of the inserted fragments was established by digestion and 
confirmed by sequencing. The pGL3 constructs with the reverse 
orientation were used as negative controls. The pGL3 constructs with 
mutated target sites for miR-494 were generated using specific 
primers (Table MM1) and the QuikChangeMutagenesis kit (Agilent 
Technologies, Santa Clara, CA, USA).  
The pGL3 constructs (100 ng) were cotransfected with the Renilla 
luciferase reporter plasmid (20 ng) as an internal control using 
Lipofectamine 2000 (Invitrogen). Luciferase activity was measured at 
48 h after transfection of IMR90 cells using a dual luciferase reporter 
assay (Promega) according to manufacturer’s instructions and 
performed on a 20/20n Luminometer (Turner BioSystems, Sunnyvale, 
CA, USA). Relative luciferase activity was calculated by normalizing 
the firefly luminescence to the Renilla luminescence.  
Plasmids driving the expression of FLAG-hnRNPA3 or FLAG-
RAD23B were prepared by inserting into the EcoRI/BamHI-digested 
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p3xFLAG-CMV 7-1 plasmid (Sigma-Aldrich) the coding regions of 
human hnRNPA3 [Integrated Molecular Analysis of Genomes and 
Their Expression (IMAGE) Consortium ID: 8322522] or human 
RAD23B (IMAGE ID: 3906269) (Thermo Scientific Italia, Rodano, 
Italy) obtained with specific primers (Table MM2) by polymerase 
chain reaction (PCR). IMR90 cells at PDL33 were first transfected 
with expressing plasmids using Lipofectamine 2000 (Invitrogen) for 
24 h and sequentially transfected with synthetic premiRs (100nM) by 
using Lipofectamine RNAiMAX transfection reagent. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Gene name Forward primer sequence Reverse primer sequence 
hnRNPA3-WT 5’-ATCATTCTAGAGGATCCTGTAAGGATTGTTAGCCTATCTA-3’ 5’-ATCATTCTAGAAGTCACATGAACATTGTGAAGT-3’ 
PDIA3-WT 5’-ATCATTCTAGAGGATCCCCACGCAGCTGAGCTTAC-3’ 5’-ATCATTCTAGAGAATGGTACTGCCTTTCCCA-3’ 
RAD23B-WT 5’-ATCATTCTAGAGGATCCCTTCCCTCAGCAGAAACG-3’ 5’-ATCATTCTAGATACCATTTCTTTTTGAAAGCAATA-3’ 
SYNCRIP-WT 5’-ATCATTCTAGAGGATCCAAAACTGACAATTGTACAGCGAA-3’ 5’-ATCATTCTAGACCAATGAATACTTATTGACAAATT-3’ 
hnRNPA3-MUT2 5’-CAGAAGTGTTCTGTAATGGATTCAGATCAATCATTTGTAGTATAATGAAATG-3’ 5’-CATTTCATTATACTACAAATGATTGATCTGAATCCATTACAGAACACTTCTG-3’ 
PDIA3-MUT2 5’-GCATCACGCAGTTTCATCCAAGTTCAATCAGGAATTGCTGACACTGCTG-3’ 5’-CAGCAGTGTCAGCAATTCCTGATTGAACTTGGATGAAACTGCGTGATGC-3’ 
RAD23B-MUT2 5’-GCTGATTCAGTTCAAAATTAATGCAAATCAATCAAAACTGGGTTTCTGATATTTG-3’ 5’-CAAATATCAGAAACCCAGTTTTGATTGATTTGCATTAATTTTGAACTGAATCAGC-3’ 
SINCRYP-MUT2 5’-GAATAGTGGTTGCCAATAGCCTGTATCAATCACATTAATTGGTTTTTTGTTATC-3’ 5’-GATAACAAAAAACCAATTAATGTGATTGATACAGGCTATTGGCAACCACTATTC-3’ 
Gene 
name Forward primer sequence Reverse primer sequence 
hnRNPA3-
FLAG 5’-CAACTGGAATTCGGAGGTAAAACCGCCGCCC-3’ 5’-ATAGCGGATCCTTAGAACCTTCTGCTACCATATC-3’ 
RAD23B-
FLAG 5’-ATAGCGAATTCGCAGGTCACCCTGAAGACC-3’ 5’-ATAGCGGATCCTCAATCTTCATCAAAGTTCTGCT-3’ 
Table MM1: Oligonucleotides sequences used for wild type (WT) and point 
mutation (MUT2) Luciferase-3’UTRs constructs (“seed” interacting sequences are in 
bold and mutated bases are underscored). 
Table MM2: Oligonucleotides sequences for hnRNPA3-FLAG and RAD23B-
FLAG constructs 
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2.5 Western blotting 
 
Cells were lysed by resuspension in a buffer containing 0.02 M 
HEPES (pH 7.9), 0.4 M NaCl, 0.1% Nonidet P-40, 10% v/v glycerol, 
1 mM NaF, 1 mM sodium orthovanadate, and a protease inhibitor 
cocktail (Sigma-Aldrich). Extracts were subjected to SDS-PAGE, 
followed by blotting onto PVDF membranes. The blots were probed 
with antibodies of hnRNPA3 (sc-133665), PDIA3 (sc-23886), 
RAD23B (sc-390019), SYNCRIP/hnRNPQ (sc-56703), LEPRE1 (sc-
393003), LIMA1 (sc-136399), MAGOH (sc-271365), p21 (sc-6246), 
p53 (sc-126), PCNA  (sc-56), tubulin (sc-8035) and vinculin (sc-7649) 
from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody of 
FLAG M2 was from Sigma-Aldrich. 
 
2.6 Reverse transcriptional and real-time qPCR 
 
Total RNA was extracted with TRIzol Reagent (Invitrogen) and 
quantified by Nanodrop (Thermo Scientific, Wilmington, DE). RNA 
preparations were treated with DNase I Amp Grade (Invitrogen) 
before the cDNAs were synthesized using random primers and iScript 
cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA, USA). 
Transcript levels were quantified using IQ SYBR green Supermix 
(Bio-Rad) on a CFX96 Real-Time System instrument (Bio-Rad) and 
primers in different exons of the same gene were designed to detect 
the levels of mRNAs (Table MM3). 
Real-Time qPCRs were performed in triplicate and relative fold 
changes were calculated using the 2-∆∆Ct method by the formula: 2-
(sample ∆Ct – control ∆Ct), where ∆Ct is the difference between the 
amplification fluorescent thresholds of the gene of interest and the 
internal reference gene (β2-microglobulin) used for normalization 
(64). 
To detect the expression of mature miR-494, total RNA was extracted 
with TRIzol reagent, and miR levels were evaluated by using the 
TaqMan MiRNA Assay kit (Applied Biosystems, Foster City, CA, 
USA; (28). PCR reactions were performed in triplicate. Small 
nucleolar RNA RNU6 (Applied Biosystems) was used for 
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normalization. 
 
 
 
 
 
 
 
2.7 Senescence-associated β-galactosidase assay 
 
Senescence-associated β-galactosidase (SA-β-gal) activity was 
assayed according to Dimri et al. (65). Briefly, cells were washed with 
PBS, fixed with 2% formaldehyde and 0.2% glutaraldehyde in PBS 
and then equilibrated in PBS. Cells were stained in X-gal staining 
solution [20 mg/ml X-gal, 40 mM citric acid/sodium phosphate pH 
6.0, 5 mM K3(FeC6N6), 5 mM K4(FeC6N6), 150 mM NaCl, and 2 mM 
MgCl2], at 37 °C, overnight. The percentage of positively stained 
cells was determined by counting 5 random fields of at least 200 cells 
each. Images were taken using a Leica AF 6000 (Leica Microsystems, 
Germany) microscope with Leica Application Suite V4 (LAS V4.1) 
software. 
 
Gene name Forward primer sequence Reverse primer sequence 
β2-microglobulin 5’-CCGTGGCCTTAGCTGTGCT-3’ 5’-TCGGATGGATGAAACCCAGA-3’ 
COL1A1 5’- AAGACGAAGACATCCCACCA -3’ 5’- AGATCACGTCATCGCACAAC -3’ 
EEF2 5’- GGAGTCGGGAGAGCATATCA -3’ 5’- GCACGTTCGACTCTTCACTG -3’ 
FUBP1 5’- GACAGGTTGATTATACCAAGGCTTG -3’ 5’-  ATAATCTGGCTGACCACCTGGA -3’ 
LEPRE1 5’- CGAAGAGATGGAGCTGGAGT -3’ 5’- CTTCCTGTGGCTGTTCCTCT -3’ 
LEPREL1 5’- AGAGAAGCCAAGCCACACAT -3’ 5’- GGCAAGTTCCCTCACACATT -3’ 
LIMA1α/β 5’- CTGCGTGGAATGTCAGAAGA -3’ 5’- GCCCAAAGCCTTCATCATAG -3’ 
MAD1L1 5’- TGGGCCTGAGCATCAGGA -3’ 5’- TTCAAGGCAAGCTCCCTCTG -3’ 
MAGOHA 5’- TTCAGGCTCGGTTGTCTTTT -3’ 5’- CAGTTCCTCCATCACGCTTT -3’ 
MAGOHB 5’- GCGATTTCTACCTGCGCTAC -3’ 5’- GAGGCCACAAAGCATCATCT -3’ 
MAPRE1 5’- GACGACGAGGCAGCTGAGTT -3’ 5’- TTCCGTAGCTTTCCGAAGTAGAA -3’ 
XRCC5 5’- CAGGTTCTCAACAGGCTGACTTC -3’ 5’- AACTTCTTTCCTATTGTTTCATGTTGAA -3’ 
Table MM3: Oligonucleotides sequences for RT-qPCR assay  
 20 
Materials and Methods 
 
2.8 Comet assay 
 
The neutral comet assay (Trevigen, Gaithersburg, MD, USA) was 
carried out according to manufacturer’s recommendations. Slides were 
incubated in lysis buffer for 30 min and in alkaline solution (pH _13) 
for 40 min; comet tails were generated by 15 min electrophoresis in 
TBE buffer at 20 V and 4°C. Slides were stained with SYBER Green, 
and DNA migration was analyzed by fluorescence microscopy (Leica 
DMS 4000B; Leica Microsystems, Wetzlar, Germany). The tail 
moment was determined using the Comet assay II software 
(Perceptive Instruments, Bury St. Edmonds, UK) as described 
previously (28). A minimum of 100 cells/experiment was analyzed. 
All the experiments were performed in triplicate. 
 
 
2.9 Chromatin Immunoprecipitation (ChiP)-qPCR assays 
 
Chromatin Immunoprecipitation (ChiP)-qPCR assays were performed 
as already described (66), with some modifications. We used three 
independent biological replicates of IMR90 at PDL34, IMR90 at 
PDL58 or IMR90 treated with DEM (IMR90-DEM). To cross-link 
DNA and proteins, formaldehyde was added directly to culture 
medium (1% v/v final concentration), for 10 min, at room 
temperature. Then, cells were neutralized with addition of 125 mM 
glycine, washed three times and scraped into ice-cold PBS. Pellets 
were resuspended in lysis buffer (1% SDS, 10 mM EDTA, 50 mM 
Tris-HCl pH 8) supplemented with protease inhibitor cocktail 
(Sigma). Sonicated chromatin (DNA fragment length of 400 to 1000 
bp) was diluted to reach 4 mL into 1% Triton, 2 mM EDTA, 150 mM 
NaCl, 20 mM Tris-HCl pH 8, protease inhibitor cocktail and 
quantified. Of these, 400 µg for each sample was stored as DNA input 
sample or used for Chip-immunoprecipitation with anti-H3K4-me3 or 
anti-H3K27me3 or normal rabbit IgGs (negative control) antibodies 
from Millipore (Millipore, Billerica, MA, USA), according to the 
manufacturer’s recommendations. After incubations at 4 °C, 
overnight, 40 µl of protein A/G Plus-Agarose (sc-2003, Santa Cruz) 
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were added to each sample and incubation continued for additional 2 
h. Chromatin-antibody/protein A/G Plus-Agarose complexes were 
centrifuged and sequentially washed once with: i) Low Salt Buffer 
(0.1% SDS, 1% Triton, 2 mM EDTA, 150 mM NaCl, 20 mM Tris-
HCl pH 8), ii) High Salt Buffer (Low Salt containing 500 mM NaCl), 
iii) LiCl Buffer (0.25 M LiCl, 0.5% NP-40, 0.5% Na-deoxycholate, 1 
mM EDTA, 10 mM Tris-HCl pH 8), and twice with TE Buffer. DNA 
and proteins were recovered after their incubation in 1% SDS, 0.1 M 
NaHCO3, at 65 °C, for 2 h. Then, NaCl was added to a 10 mM final 
concentration and protein-DNA cross-links were reversed by 
incubating samples, at 65 °C, overnight. Samples were digested with 
proteinase K, at 45 °C, for 1 h. DNA was purified by phenol-
chloroform extraction and resuspended in 20 µl for quantification. 
DNA input sample cross-links were reversed in a similar manner. 
Real-Time qPCR was performed in triplicate on 1/40 of the 
immunoprecipitated materials or 1/400 of the input, by using oligos 
specific for each gene promoter (Table MM4). The relative 
enrichment of co-immunoprecipitated promoter fragments was 
determined based on the threshold cycle (Ct) values, as described 
before (67). Briefly, in the three conditions for each promoter, fold 
changes of H3K4me3 or H3K27me3 ChIPs relative to control IgGs 
ChIP were calculated by the following formula: 2-∆∆Ct. ∆∆Ct values 
represent the difference of the ∆Ct value obtained after 
immunoprecipitation with a determined antibody and the ∆Ct value 
for the corresponding sample immunoprecipitated with negative 
control (rabbit IgGs). In each condition, ∆Ct values for specific 
promoters were determined by subtracting the Ct value of the input 
from the Ct value obtained in the same sample after 
immunoprecipitation with the antibodies of interest. 
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2.10 Statistical analysis 
 
Statistical analyses were carried out using the Student’s t-test; data 
were considered significant at a value of p ≤ 0.05 (***) or p ≤ 0.01 
(*). 
 
 
 
 
 
 
 
 
 
 
 
LEPRE1-promoter 
5’-CCACCGACTCACAATGACAG-3’ 
5’-CTTTCGGCTCAGACCTCACT-3’ 
LIMA1α-promoter 5’-ACTATGGGTGTGCACCACTG -3’ 5’-GAGACCAGCCAGACCAACAT -3’ 
MAGOHA-promoter 5’-GCAGCCAGGCAGAGAATTAC -3’ 
5’-AGGTGCTGGGAGACGTTAGA -3’ 
MAGOHB-promoter 5’-TGCCAAAACTTCACAGGCTA -3’ 5’-TGACAGTCACCGTGCTTTTT -3’ 
Table MM4: Oligonucleotides sequences for Chip-qPCR assay  
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3. Results 
3.1 Proteomic analysis by Two Dimensional-Difference Gel 
Electrophoresis (2D-DIGE) coupled to Mass Spectrometry  (MS) 
and bioinformatic prediction of putative miRNA-494 targets. 
 
A previous study of our laboratory has recently demonstrated that 
cellular senescence of IMR90 fibroblasts is accompanied by a vast 
deregulation of microRNA expression. Functional studies 
demonstrated that among the up-regulated miRNAs, a set of them 
(miR-210, miR-376a*, miR-486-5p, miR-494, miR-542-5p) promotes 
the senescence program when transfected in young cells (28). In 
particular, miR-494 elicit the most robust effects, as demonstrated by 
induction of specific markers of senescence.  
To identify the direct targets of miR-494, we employed a quantitative 
proteomic strategy based on the consideration that functional miRNA-
target interactions lead to reduced levels of proteins derived from the 
corresponding transcripts. 
We carried out a proteomic analysis by 2D-DIGE at 96 h after 
transfection of miR-494; in these conditions, protein levels of cyclin-
dependent kinase 6 (CDK6) and cyclin D1, two known targets of 
miR-494, were strongly reduced (data not shown). Total protein 
samples derived from IMR90-miR-scramble and IMR90-miR-494 
transfected cells were differentially labeled with Cy3 (green) or Cy5 
(red) dyes, mixed and separated by 2D-DIGE.  
The DeCyder Differential Analysis Software was used to localize and 
analyze the protein spots within a gel and also to perform comparative 
statistical analysis throughout the gels. With this analysis, 
approximately 2700 protein spots were resolved within a pH 3-10 
range and 10-120 kDa molecular mass ranges and of these about 1500 
protein spots were matched between the different gels. Among these, 
the DeCyder analysis reveals that 102 protein spots (38 up- and 64 
down-regulated) were differential expressed in miR-494 transfected 
cells compared to miR-scramble control, with average ratio greater or 
equal to 1.50 for up- and less than or equal to -1.50 for down-
regulated protein spots (p < 0.05). To automatically pick these up- and 
down-regulated protein spots, a preparative gel was stained with 
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SYPRO Ruby (Figure 3). Picked spots were digested with trypsin and 
then analyzed by nanoLC-ESI-LIT-MS/MS (nano-Liquid 
Chromatography coupled to ElectroSpray-Linear Ion Trap-tandem 
Mass Spectrometry). This analysis revealed that a total of 172 protein 
species were present in the deregulated spots due to the occurrence of 
comigrating proteins in the same spot or of the same protein in more 
than one spot.  
We focused our subsequent analyses on the 121 proteins present in the 
down-regulated spots, since they could be putative targets of miR-494. 
Very interesting, among these proteins, BUB3, lamin B1, manganese 
superoxide dismutase (MnSOD), peroxideroxin-1 (PRDX1) and 
XRCC5/Ku80 were identified and previously reported as linked to 
senescence (68-72), thus confirming the validity of our approach.  
To search putative direct target of miR-494, we performed in silico 
analysis with 5 different algorithms (TargetScan 6.2, miRDB, 
miRanda, PITA, and RNA hybrid) on the respective mRNAs of the 
121 down-regulated proteins after miR-494 over-expression.  
We selected putative targets following two levels of stringency. The 
first one was based on the intersections of 3 different algorithms, 
which allow us to select 26 putative targets of miR-494 (Table 1). In a 
second level of stringency, we filtered these 26 putative targets for 
conservation among mammals and found 7 genes with highly 
conserved- and 19 with poorly conserved-seed region.   
Based on this analysis, we decided to investigate if the 3’UTRs of 
COG3, EIF5, ENAH, GK, hnRNPA3, RAD23B, and 
SYNCRIP/hnRNPQ (hereinafter called SYNCRIP) contain functional 
sites for miR-494. Furthermore, among the remaining putative miR-
494 targets having poorly conserved miR-494 binding sites in their 
3’UTRs, we selected MAPRE1 and PDIA3 as representative genes 
because of the high abundance of the corresponding proteins in 2D-
DIGE/MS analysis. 
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Figure 3: Proteomic strategy based on 2D-DIGE/MS analysis coupled to 
bioinformatic prediction of miRNA-494 targets.  In figure is showed the scan of 
the preparative gel stained with SYPRO Ruby. The up-represented and down-
represented spots are numbered (black and white, respectively). 
By bioinformatics tools (TargetScan, miRDB, RNAhybrid, miRanda and PITA) we 
search for miR-494 potential targets among the transcripts corresponding to the 
121 down-regulated proteins. Among the 26 putative miR-494 targets, predicted by 
at least 3 algorithms, we selected a subset of 9 genes.  In this group are included 
the 7 genes with highly conserved miR-494 sites and 2 with poorly conserved sites, 
as the latter were high abundant in 2D-DIGE/MS.  
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Table 1. List of 26 putative miR-494 targets predicted by in silico computational 
analysis. 
 
 
 
         
 
 
 
 
  
Gene 
symbol 
  
Gene name 
 
Accession 
number* 
 
Target prediction programs  
  
N. conserved/ 
poorly 
conserved sites 
(TargetScan) 
 ACTR3 Actin-related protein 3 
 
NM_005721 
 
 TargetScan, miRanda, PITA, RNA hybrid 
 
0/1 
ARPC5 
Actin related protein 2/3 
complex, subunit 5 
NM_005717 TargetScan, miRanda,  PITA, RNA hybrid 0/2 
CBX1 
Chromobox protein 
homolog 1 
NM_006807 TargetScan, PITA, RNA hybrid 0/1 
CHCHD3 
Coiled-coil-helix-coiled-
coil-helix domain 
containing 3 
NM_017812 TargetScan, miRanda, miRDB, PITA 
 
0/1 
 
CNN3 
Calponin 3, acidic NM_001839 TargetScan, miRanda, PITA, RNA hybrid 0/1 
COG3 
Component of 
oligomeric golgi 
complex3 
NM_031431 TargetScan, miRanda, PITA, RNA hybrid 1/0 
EIF5 
Eukaryotic translation 
initiation factor 5 
NM_001969 
NM_183004 
TargetScan, miRanda, miRDB, PITA, RNA 
hybrid 
1/1 
ENAH 
Enabled homolog 
(Drosophila) 
NM_001008493 
NM_018212 
TargetScan, miRanda, miRDB, PITA, RNA 
hybrid 
1/3 
 
FXR1 
Fragile X mental 
retardation syndrome-
related protein 1 
      
NM_001013438 
TargetScan, miRanda, miRDB, PITA, RNA 
hybrid 
0/2 
NM_005087 
NM_00101349 
TargetScan, miRDB, RNA hybrid 0/2 
 
GK 
Glycerol kinase NM_000167 TargetScan, miRanda, miRDB, PITA 1/3 
 
GLO1 
Lactoylglutathione lyase NM_006708 TargetScan, miRanda, PITA, RNA hybrid 0/1 
GOT2 
Aspartate 
aminotransferase, 
mitochondrial 
NM_002080 TargetScan, miRanda, PITA, RNA hybrid 0/1 
GRSF1 G-rich sequence factor 1 
NM_001098477 
NM_002092 
TargetScan, PITA, RNA hybrid 0/2 
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                    * Accession numbers correspond to those reported in TargetScan 6.2 
   ** Out of the seven transcript variants, only two are reported that are representative 
of the two different 3’UTRs of   the  SYNCRIP mRNAs.  
hnRNPA3 
Heterogeneous nuclear 
ribonucleoprotein A3 
NM_194247 
TargetScan, miRanda, miRDB, PITA, RNA 
hybrid 
1/0 
MAPK1 
Mitogen-activated 
protein kinase 1 
NM_002745    TargetScan, PITA, RNA hybrid 0/1 
MAPRE1 
Microtubule-associated 
protein RP/EB family 
member 1 
NM_012325    TargetScan, PITA, RNA hybrid 0/1 
 
PARVA 
Alpha-parvin NM_018222 TargetScan, PITA, RNA hybrid 0/2 
PDIA3 
Protein disulfide-
isomerase A3 
NM_005313 TargetScan, MiRanda, PITA, RNA hybrid 0/1 
PGAM1 
Phosphoglycerate 
mutase 1 
NM_002629 TargetScan, PITA, RNA hybrid 0/1 
PSME3 
Proteasome activator 
complex subunit 3 
NM_005789 
NM_176863 
miRanda, PITA, RNA hybrid 0/0 
RAD23B 
UV excision repair 
protein RAD23 homolog 
B 
NM_002874 
TargetScan, miRanda, miRDB , PITA, RNA 
hybrid 
1/1 
RAI14 Retinoic acid induced 14 
NM_015577 
TargetScan, miRanda, miRDB, PITA, RNA 
hybrid 
0/3 
NM_001145523 TargetScan, miRanda, miRDB, RNA hybrid 0/3 
SRI Sorcin NM_198901 TargetScan, miRanda, PITA, RNA hybrid 0/1 
STAT1 
Signal transducer and 
activator of 
transcription 1 
   NM_007315 
TargetScan, miRanda, miRDB, PITA, RNA 
hybrid 
0/3 
 SYNCRIP/ 
hnRNPQ 
Synaptotagmin binding, 
cytoplasmic RNA 
interacting protein 
NM_006372** 
  
TargetScan, miRanda, miRDB, PITA, RNA 
hybrid  
1/0 
  
NM_001159673** TargetScan, miRanda, miRDB, RNA hybrid 2/0 
WDFY1 
WD repeat and FYVE 
domain containing 1 
  
NM_020830   
TargetScan, miRanda, miRDB, PITA, RNA 
hybrid 
0/2 
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3.2 hnRNPA3, PDIA3, RAD23B and SYNCRIP -3’UTRs are real 
direct targets of miR-494 
 
The functional studies were performed using constructs containing the 
regions (200 bp) encompassing the miR-494 recognized sites of the 9 
selected genes, cloned downstream of the luciferase genes.  
These report plasmids were co-transfected in presence of premiR 
negative control (miR-SCR) or premiR-494 in IMR90 cells and the 
luciferase activity was assessed. As shown in Figure 4A, over-
expression of miR-494 significantly (p <0.05) inhibited the activity of 
the reporter constructs bearing the wild-type (WT) 3’UTRs of 
hnRNPA3, RAD23B, SYNCRIP  and PDIA3 genes in IMR90 cells 
when compared with miR-SCR-transfected cells.  
To validate these results we also used for each gene, 2 constructs that 
contain the same regions but in inverted orientation (MUT1) or point-
mutations in the binding sites of miR-494 (MUT2). These 
experiments showed that both mutants abolish the effect of miR-494. 
These results indicate that hnRNPA3, RAD23B, SYNCRIP and 
PDIA3 are direct targets of miR-494 in IMR90 cells.  
Next, by Western blotting experiments, we examined the endogenous 
expression of hnRNPA3, RAD23B, SYNCRIP and PDIA3 after miR-
494 over-expression  in IMR90 cells at PDL33. Figure 4B shows that 
protein levels of above genes were significantly reduced in IMR90 
cells expressing high levels of miR-494 when compared with the 
scrambled control.  
Then, to investigate whether the decrease of endogenous miR-494 was 
able to increase the expression of the above genes, we transfected 
IMR90 at PDL33 with either a miR-494 inhibitor (anti-sense 
oligonucleotide ASO-494) or an ASO negative control (ASO-cont). 
As shown in figure 4B, protein levels of  hnRNPA3, RAD23B, 
SYNCRIP and PDIA3 were  up-regulated while RAD23B slightly 
increased upon ASO-494 transfection. This up-regulation is 
comparable to that observed for PTEN, a known miR-494 target  (data 
not shown).  
Overall, these results demonstrate that hnRNPA3, RAD23B, 
SYNCRIP and PDIA3 contain functional binding sites for miR-494.   
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Figure 4: hnRNPA3, PDIA3, RAD23B and SYNCRIP are direct targets of miR-
494. A) hnRNPA3, PDIA3, RAD23B and SYNCRIP miR-494 targets were validated 
by luciferase assay in IMR90 cells. Cells at PDL33 were transfected with luciferase 
constructs bearing wild-type 3’-UTRs (WT) or inverted (MUT1) or mutated in the 
seed sequence (MUT2) of miR-494. Cells were also cotransfected with either 100 nM 
of premiR-494 (miR-494) or premiR negative control (miR-SCR). Renilla luciferase 
was used as an internal control. Triplicate transfection ratio (±SD) firefly/Renilla 
luciferase activity were averaged and expressed as percentage of the corresponding 
transfections with miR-SCR control. ***p < 0.05. B) IMR90 cells (PDL33) were 
electroporated with either negative control (miR-SCR) or premiR-494 (miR-494) and 
proteins were harvested at 4 d. The same cells were also electroporated with either 
ASO control (ASO-cont) or ASO-miR-494 (ASO-494) and harvested at 4 d. The 
protein levels were analyzed by Western blotting experiments. Vinculin was used as a 
loading control. 
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3.3 hnRNPA3, PDIA3, RAD23B and SYNCRIP are down-
regulated in different models of senescence. 
 
To investigate if downregulation of hnRNPA3, PDIA3, RAD23B and 
SYNCRIP is a general phenomenon occuring in senescence, we tested 
expression of these genes in 3 other different senescence models: i) in 
replicative senescent IMR90 cells at PDL60, ii) in WI38 fibroblasts 
that are senescent at passage 23 and iii) in stress-induced senescence 
of IMR90 after chronic DEM treatment (28). In these senescence 
models, cells showed elevated SA-β-gal-positive staining, increased 
p53 and p21 protein levels as well as down-regulation of PCNA (data 
not shown). 
As shown in Figure 5A, protein levels of hnRNPA3, PDIA3, 
RAD23B and SYNCRIP are down-regulated in replicative senescent 
IMR90 cells and as expected, this well correlate with a significant up-
regulation of miR-494 levels in the same population. 
In replicative senescent WI38 cells (Figure 5A) we obtained a similar 
down-regulation of the miR-494 putative targets with exception of 
RAD23B. Also in replicative senescence of WI38, miR-494 levels 
were significantly increased when compared to young cells. 
Lastly, oxidative stress-induced premature senescence in IMR90 cells 
(Figure 5B) provokes a down-regulation of PDIA3, RAD23B and 
SYNCRIP proteins and this is accompanied by significantly up-
regulation of miR-494 expression. 
All together, our data revealed that up-regulation of miR-494 and 
afterwards down-regulation of its targets, is a general phenomenon in 
senescence. 
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Figure 5: hnRNPA3, PDIA3, RAD23B and SYNCRIP are down-regulated in 
different models of senescence. A) Western blotting analyses of hnRNPA3, PDIA3, 
RAD23B and SYNCRIP expression in two models of replicative senescence: IMR90 
at PDL 60 and WI38 at passage 23. Vinculin was used as loading control. In the 
same panel, on the right, the levels of miR-494 in the respective senescent cell 
populations are reported. miR-494 expression was evaluated by RT-qPCR after 
normalizing to RNU6 expression and are reported as relative to PDL33-control cells. 
Columns represent means ±SD of 3 independent populations. ***p <0.05. B) IMR90 
cells at PDL33 were treated with DEM (100 µM) for 10 d (IMR90-DEM), and 
protein levels of hnRNPA3, PDIA3, RAD23B, and SYNCRIP were examined by 
Western blotting. Vinculin was used as a loading control. Analyses of miR-494 
expression (right panel), in control (IMR90-C) and DEM-senescent IMR90 cells 
(IMR90-DEM) were performed as described in B. Columns represent means ±SD of 
3 independent cell populations. ***p <0.05. 
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3.4 Functional effects of down-regulation of miR-494 targets in 
young IMR90 cells 
 
To establish whether down-regulation of hnRNPA3, PDIA3, RAD23B 
and SYNCRIP is causally related to senescence, we silenced them in 
young IMR90 cells by RNA interference-mediated knockdown 
(siRNA), and evaluated the appearance of senescent phenotypes by 
testing specific markers such as cellular proliferation, SA-β-gal 
activity and DNA damage. Knockdown of PDIA3 cells by siRNA  
transfection was cytotoxic in young cells; thus, this gene was not 
further investigated.  
Data obtained with the silencing of SYNCRIP have shown that down-
regulation of this gene is not causally involved in senescence because 
no evident markers were detected after siRNA transfection. On the 
contrary, as shown in Figure 6A, downregulation of hnRNPA3 or 
RAD23B caused a strong reduction in cell growth (p < 0.05) in a 
time-dependent manner, compared  with the negative siRNA control. 
In parallel, we tested the SA-β-gal activity after silencing of 
hnRNPA3 and RAD23B and the results demontrate that siRNA-
mediated down-regulation of hnRNPA3 or RAD23B caused a robust 
increase of SA−β-gal activity (Figure 6B). Furthemore, we used 
neutral comet assay to assess if silencing of hnRNPA3 and RAD23B 
were able to induce a DNA damage by accumulation of double-strand 
DNA breaks. Results shown Figure 6C, demonstate that reduction of 
hnRNPA3 or RAD23B levels induced accumulation of  double-strand 
DNA breaks when compared with controls. We have used etoposide- 
and negative siRNA control-treated cells as positive or negative 
controls, respectively.  
Finally, in order to confirm the senescence-like phenotype induced by 
knockdown of hnRNPA3 and RAD23B, we tested the protein levels 
of senescence molecular markers such as p53, PCNA and p21. The 
obtained results showed that p53 and its direct transcriptional target 
p21 are induced upon siRNA-mediated downregulation of hnRNPA3 
or RAD23B . 
Overall, these results indicate that  hnRNPA3 and RAD23B are 
effectors of the miR-494-induced senescent phenotype and that 
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cellular senescence induced either by hnRNPA3 or RAD23B 
knockdown was associated with up-regulation of p53 and p21 proteins 
(Figure 6D), a key signaling pathways of senescence onset. 
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Figure 6: Functional effects of hnRNPA3 and  RAD23B down-regulation in 
young IMR90 cells. A) IMR90 cells at PDL33 were transfected in triplicate with 
siRNA-negative control or with indicated siRNAs and plated into 6-well plates 
(50,000 cells/well). Cell counts were performed at indicated time points. Bars 
represent means ±SD. ***p < 0.05. B) SA-β-gal activity was detected by X-gal 
staining at 7 d after transfection with siRNAs for hnRNPA3 and RAD23. Counts of  
>300 cells were averaged and expressed as fold change ±SD  with respect to the 
siRNA negative control. ***p < 0.05. C) Indicated siRNAs were transfected in 
PDL33 IMR90 cells. After 4 d, cells were harvested, and comet tails were generated 
by electrophoresis. Slides were stained with SYBER Green, and DNA migration was 
analyzed by fluorescence microscopy. Tail moment was determined, and nuclei were 
divided into 2 classes based on the value of the tail moment. Percentage of damaged 
cells (tail moment >6) is indicated by the bar graphs. A minimum of 100 
cells/experiment was analyzed. ***p <0.05. D) Analyses of the senescence molecular 
markers p53, PCNA, and p21 proteins by  Western blotting were performed at 4 d 
after transfection of the indicated siRNAs. Vinculin was used as a loading control. 
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3.5 Role of the miR-494 targets in the senescence program 
 
To establish definitively that hnRNPA3 and RAD23B are real 
effectors of miR-494-induced senescence we have ectopically 
expressed these genes individually and verified if this condition was 
able to delay the senescence triggered by miR-494. 
In this experiment young IMR90 cells were first transfected with 
plasmids driving the expression of hnRNPA3 and RAD23B, lacking 
3’UTR, and thus refractory to miR-494, or empty vector, and 
sequentially transfected with premiR-494. 
As shown in Figure 7, the ectopic expression of hnRNPA3 or 
RAD23B slowed the appearance of the senescent phenotype induced 
by over-expression of miR-494 in young IMR90 cells. In fact, the cell 
number was significantly increased when the cells were transfected 
with hnRNPA3 or RAD23B, compared with cells transfected with the 
empy vector  (Figure 7A). These results well correlate with the data of 
SA-b-gal assay (Figure 7B), where the increase of positive cells was 
hampered by ectopic expression of hnRNPA3 or RAD23B. Finally, 
Western blotting experiments showed that this delay is accompanied 
by reduced protein levels of p53 and p21 (Figure 7C, compare lines 2, 
4, and 6).   
The results suggest that over-expression of hnRNPA3 or RAD23B 
slow down the appearance of the markers of senescence induced by 
miR-494 in young IMR90 cells. 
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Figure 7: Ectopic expression of hnRNPA3 or RAD23B in young IMR90 cells 
hampers the senescence process induced by miR-494.  A) IMR90 cells at PDL33 
were transfected with plasmids driving the expression of either hnRNPA3 or 
RAD23B, lacking 3’UTRs, or empty vector. After 24 h, the same cells were 
transfected with 100 nM of premiR-494 (miR-494) or premiR negative control 
(miR-SCR) for 4 d. Cell numbers were assessed and counts expressed as fold 
change ±SD with respect to the negative control. B) SA-β-gal activity was detected 
by X-gal staining at 7 d after transfection with premiR-494. Counts of  >300 cells 
were averaged and expressed as fold change ±SD with respect to the scrambled 
negative control. C) Western blotting analysis of p53 and p21 was performed at 4 d 
after transfection with miR-494. Vinculin was used as a loading control. Columns 
represent means ±SD of >3 independent experiments. ***p <0.05. 
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3.6 Comparative proteomic analysis of IMR90 senescence induced  
either by telomere shortening or by oxidative stress.  
To identify novel genes acting as common mediators of the 
senescence process in IMR90, we performed comparative differential 
proteomic analyses based on 2D-DIGE.  
We used total protein extracts from cells induced to senescence either 
by telomere shortening after serial passage in vitro (IMR90 at PDL58) 
or by oxidative stress provoked by chronic mild treatment with the 
glutathione-depleting agent diethylmaleate (DEM-treated IMR90 
cells) and young untreated control cells (IMR90 at PDL34). 
Approximately 2,500 protein spots were resolved within a pH 3-10 
range and 10-120 kDa molecular mass range and about 1,400 valid 
spots were matched throughout the gels for DeCyder statistical 
analysis. Following quantitative and statistical analysis and using as 
selection criteria fold changes >1.50 for spots up-represented (3 in 
number) and <−1.50 for spots down-represented (17 in number) and p 
value ≤ 0.05, we identified 20 protein spots that were significantly 
modified in both conditions of senescence (Figure 8A).  
NanoLC-ESI-LIT-MS/MS analysis on these 20 common deregulated 
protein spots identified 25 protein species (Table 2) due to the 
occurrence of comigrating proteins in the same spot or of the same 
protein in more than one spot. Of note, among the up-represented or 
down-represented identified proteins we found some proteins which 
have been already associated with senescence, such as vimentin 
(VIM), cathepsin B (CTSB), collagen alpha-1 (I) chain (COL1A1) 
and collagen alpha-2 (I) chain (COL1A2), thus validating our 
approach. 
To evaluate whether the identified 25 proteins  with altered 
abundances are also regulated at transcriptional level, total RNA was 
extracted from three independent cell populations for each condition 
of senescence and the expression levels of these genes were analyzed 
by RT-qPCR. As reported in Figure 8B, among the 23 genes encoding 
for the proteins identified within the down-represented spots, 10 
genes, COL1A1, EEF2, FUBP1, LEPRE1, LIMA1, MAD1L1, 
MAGOHA, MAGOHB, MAPRE1 and XRCC5, were significantly (p  
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≤ 0.05) down-regulated at least 2 fold at RNA transcriptional levels in 
both replicative and stress induced-senescence.  
Overall these results, demonstrate that replicative and stress-induced 
senescence share a subset of proteins that are commonly down-
regulated and among these more than 50% are also regulated at 
transcriptional level.    
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Figure 8: Comparative 2D-DIGE and transcriptional analysis of genes identified 
in spots common to both conditions of senescence. A) Scan of the analytical, 
“master” gel of Cy2-labelled protein mixtures from IMR90 at PDL34, replicative 
IMR90 (PDL58) and DEM-senescent IMR90 cells. In the panel, up- and down-
represented protein spots common to replicative- and DEM induced-senescent cells 
are numbered (black and white color, respectively); numbers correspond to those 
reported in Table 2. The Venn diagram represents the number of the modified protein 
spots identified in each condition of senescence and those shared between replicative 
and DEM-induced senescence. B) mRNA levels encoding for the common genes 
identified in selected spots of senescent IMR90 cells were analyzed in triplicate by 
RT-qPCR. The panel reports transcript levels of the genes (10 in number) that were 
significantly (p  ≤ 0.05) down-regulated at least 2 fold also at RNA transcriptional 
level in both types of senescence.  Relative mRNA levels in senescent cells were 
calculated by assigning the arbitrary value 1 to the amount observed in young IMR90 
cells. The β2-microglobulin transcript level was used as reference. Each column 
represents the mean ± SD of 3 independent cell populations; *p ≤ 0.05. The symbols 
of the genes correspond to those reported in Table 2.  
A 
B 
Figure 8 
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Table 2. List of the common proteins identified as differentially represented in 
replicative (PDL58) and DEM-senescent IMR90 cells as revealed by 2D-DIGE and 
nLC-ESI-LIT-MS/MS analyses. Spot numbering corresponds to that reported in 
Figure 8A. The statistical significance in differences of protein spots were assessed by 
the Student's t-test. Protein accession numbers and gene symbols are from NCBI. 
 
Maste
r No.  
(spot) 
Protein name Gene Symbol 
Matched 
peptides 
Mascot 
score 
Protein  
Mr / pI 
PDL58 vs 
PDL34 
Average ratio 
PDL58 vs 
PDL34 
t-test 
IMR90-DEM 
vs PDL34 
Average ratio 
IMR90-DEM vs 
PDL34 
t-test 
1  Vimentin VIM 21 832 53676/5.06 2.01 0.0075 3.33 0.0028 
2  Vimentin VIM 39 1510 53676/5.06 1.86 0.0075 2.91 0.0046 
3  Cathepsin B CTSB 10 393 38766/5.88 4.99 0.0012 3.77 0.012 
4  Collagen alpha-1(I) chain COL1A1 17 736 139883/5.6 -2.92 0.0084 -2.46 0.0036 
5  Collagen alpha-1(I) chain COL1A1 26 1399 139883/5.6 -2.13 0.013 -2.29 0.036 
6  Collagen alpha-2(I) chain COL1A2 27 1377 129749/9.08 -2.67 0.041 -2.4 0.043 
7  Elongation factor 2 EEF2 34 1389 96246/6.41 -1.93 0.027 -1.79 0.016 
8  Elongation factor 2 EEF2 41 1656 96246/6.41 -2.27 0.042 -2.17 0.022 
9  Elongation factor 2 EEF2 41 1706 96246/6.41 -2.53 0.00052 -1.8 0.025 
10  
Vacuolar protein sorting-
associated protein 35 VPS35 15 700 92447/5.32 
-2.22 0.038 -3.14 0.019 
Heat shock protein HSP 
90-alpha 
HSP90A
A1 6 336 85006/4.94 
LIM domain and actin-
binding protein 1 
LIMA1/E
PLIN 8 301 85630/6.41 
Prolyl 3-hydroxylase 1 LEPRE1 6 264 84196/5.05 
11 
Mitochondrial inner 
membrane protein IMMT 18 870 84026/6.08 
-3.01 0.013 -2.83 0.0069 
X-ray repair cross-
complementing protein 5 XRCC5 20 815 83222/5.55 
Procollagen-lysine-2-
oxoglutarate 5-
dioxygenase 3 
PLOD3 13 672 85302/5.69 
Mitotic spindle assembly 
checkpoint protein MAD1 MAD1L1 5 175 83301/5.72 
Niban-like protein 1  
NIBL1/ 
FAM129
B 
4 164 84598/5.82 
LIM domain and actin-
binding protein 1 
LIMA1/E
PLIN 3 153 85630/6.41 
12 
Mitochondrial inner 
membrane protein IMMT 24 1140 84026/6.08 
-2.45 0.0046 
-2.73 
0.013 
Procollagen-lysine-2-
oxoglutarate 5-
dioxygenase 3 
PLOD3 16 826 85302/5.69 
Signal transducer and 
activator of transcription 
1-alpha/beta 
STAT1 7 292 87850/5.74 
E3 ubiquitin-protein ligase 
LRSAM1 LRSAM1 5 209 84567/5.7 
13 Far upstream element (FUSE) binding protein 1 FUBP1 14 668 66362/7.12 -1.84 0.015 -1.52 0.026 
14  UDP-N-acetylhexosamine pyrophosphorylase UAP1 3 143 59131/5.92 -1.85 0.037 -1.83 0.014 
15  
Microtubule-associated 
protein RP/EB family 
member 1 
MAPRE1 15 555 30151/5.02 -1.66 0.0041 -1.7 0.034 
16  
Proteasome subunit alpha 
type-5 PSMA5 11 447 26565/ 4.74 
-2.06 0.00075 -1.87 0.0051 
Tyrosine 3-
monooxygenase/tryptopha
n 5-monooxygenase 
activation protein zeta 
polypeptide 
YWHAZ 3 87 27899/4.73 
17  
Protein mago nashi 
homolog 
MAGOH
A 3 117 17210/5.74 -21.38 3.30E-005 -24.39 3.90E-005 Protein mago nashi 
homolog 2 
MAGOH
B 3 117 17276/5.96 
18  
Ubiquitin carboxyl-
terminal hydrolase 
isozyme L3 
UCHL3 2 109 26337/4.84 -3.71 0.0017 -3.91 0.01 
19  
X-ray repair cross-
complementing protein 5 XRCC5 4 223 83222/5.55 
-3.12 0.0045 -3.08 0.014 LIM domain and actin binding 1 
LIMA1/ 
EPLIN 5 215 76661/5.66 
Prolyl 3-hydroxylase 2 LEPREL1 2 72 81846/5.48 
20  
Prolyl 3-hydroxylase 2 LEPREL1 14 648 81846/5.48 
-3.23 0.0051 -2.66 0.019 
X-ray repair cross-
complementing protein 5 XRCC5 8 378 83222/5.55 
LIM domain and actin 
binding 1 
LIMA1/ 
EPLIN 5 214 85630/6.41 
Niban-like protein 1 
NIBL1/ 
FAM129
B 
4 183 84598/5.82 
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3.7  RNA interference-mediated knockdown of LEPRE1, LIMA1, 
MAGOHA and MAGOHB induces a senescent phenotype in 
IMR90 cells. 
 
To investigate whether the down-regulation of COL1A1, EEF2, 
FUBP1, LEPRE1, LIMA1, MAD1L1, MAGOHA, MAGOHB and 
MAPRE1 and XRCC5, observed in proteomic analysis and confirmed 
in RT-qPCR experiments, was causally related to senescence, we 
analyzed the effects of their individual ectopic silencig in young 
IMR90 cells. To this aim, we evaluated specific markers of 
senescence, such as cell proliferation and SA-β-gal activity after their 
individual down-regulation by siRNAs. As displayed in  Figure 9A, 
the down-regulation of LEPRE1, LIMA1, MAGOHA and MAGOHB  
caused a significant reduction in cell growth (p ≤ 0.05) at 4 days after 
transfection, when compared with a negative siRNA control. 
Furthemore, as shown in Figure 9B, siRNA-mediated knockdown of 
LEPRE1, LIMA1, MAGOHA and MAGOHB robustly increased the 
number of SA-β-gal-positive cells, compared to cells transfected with 
siRNA control. 
To further examine at molecular level the senescence response 
induced by siRNA-mediated down-regulation of the four mentioned 
genes, we analyzed the protein levels of p53 and p21, two well known 
markers of senescence. The results indicate that ectopic down-
regulation of MAGOHA and MAGOHB led to a concomitant increase 
of p53 and p21, conversely the down-regulation of LEPRE1 and 
LIMA1 fosters senescence independently of the p53/p21 pathway 
(Figure 9C). 
All together, these results suggest that down-regulation of LEPRE1, 
LIMA1, MAGOHA and MAGOHB expression has a causative role in 
the induction of cellular senescence in primary IMR90 fibroblasts. 
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Figure 9: Functional effects of down-regulation of LEPRE1, LIMA1, MAGOHA 
and MAGOHB in young IMR90 cells. A) Young IMR90 cells were transfected in 
triplicate with siRNA negative control or with the indicated siRNAs and plated into 
six-well plates (50,000 cells/well). Cell counts were performed at 4 d after 
transfection. Bars indicate means ± SD. *p ≤ 0.05.   B) SA-β-gal activity was 
detected by X-gal staining at 7 d after transfection with siRNAs for control and for 
the indicated genes. The percentage of SA-β-gal-positive cells was calculated by 
counting > 300 cells and indicated in images. C) Western blotting analysis of p53 and 
p21 was performed at 4 d after transfection with specific siRNAs. Vinculin was used 
as a loading control.  
B 
C 
Figure 9 
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3.8 Expression analysis of LEPRE1, LIMA1, MAGOHA and 
MAGOHB protein in other  senescence  models in vitro and in 
vivo. 
 
To generalize the role of these genes in the senescence process, we  
analyzed the protein levels of LEPRE1, LIMA1, MAGOHA and 
MAGOHB in different cellular models of senescence in vitro and in 
vivo. For cellular senescence in vitro, we used human WI38 primary 
fibroblasts, in which the senescent phenotype was induced: i) after 
repeated rounds of replication in culture (reaching at passage 23); ii) 
prematurely, by treating young cells (p13) with low doses (100 µM) 
of DEM for ten days. 
In line with the results obtained by proteomic analysis and RT-pPCR 
(see Figure 8 and Table 2), we confirmed the reduction of the protein 
levels of LEPRE1, LIMA1, MAGOHA and MAGOHB genes in both 
condition of senescence, (WI38-p23 and WI38-DEM) (Figure 10A). 
Since MAGOHA and MAGOHB proteins are different only for two 
amino acid residues in the first four ones, Western blotting analysis 
displayed only one band with the commercial antibody we used.   
To address the in vivo relevance of LEPRE1, LIMA1, MAGOHA, and 
MAGOHB genes in the process of aging, we evaluated their protein 
expression levels in different cell lines of human fibroblasts from 
young (age 21–24) or old (age 87–94) subjects (Figure 10B). In these 
cells the levels of COL1A1 and MMP3 mRNAs are in agreement with 
that expected for the age of donors (data not shown). The analyses by 
Western blotting demonstrated a down-representation of protein 
amounts of the genes mentioned above in cell lines derived from old 
subjects compared to fibroblasts from young subjects. All together, 
these results indicate that the protein down-regulation of LEPRE1, 
LIMA1, MAGOHA and MAGOHB plays a relevant role in 
senescence process in vitro and also highlight an in vivo relevance 
because their expression correlate with human age. 
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A C 
Figure 10: Protein levels of LEPRE1, LIMA1, MAGOHA and MAGOHB  in 
other senescence models. A) Protein amounts of LEPRE1, LIMA1, MAGOHA and 
MAGOHB in young (p13) and replicative senescent (p23) WI38 cells. B) WI38 
untreated cells and cells treated with DEM (100 µM) for 10 days, were determined 
by Western blotting experiments. Tubulin was used as a loading control. C) Protein 
levels of LEPRE1, LIMA1, MAGOHA and MAGOHB in young IMR90 cells and in 
different cell lines from healthy donors of different ages (indicated in the panels) 
were determined by Western blotting experiments after two passages in culture. 
Tubulin was used as a loading control. YR, years. 
Figure 10 
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3.9  H3K4me3 and H3K27me3 changes of the LEPRE1, LIMA1, 
MAGOHA, and MAGOHB promoters during senescence 
 
To investigate if histone H3 methylation states could affect the 
observed gene transcription changes of LEPRE1, LIMA1, MAGOHA, 
and MAGOHB, we performed ChiP-qPCR assays on the promoters of 
the mentioned genes. In particular, we analyzed the distribution of the 
trimethylation pattern of histone H3 at Lys4 (H3K4me3), an active 
mark, and at Lys27 (H3K27me3), a repressive mark, on the region 
encompassing 500 bp from the start site of these four genes. Analysis 
was performed on young and replicative- or stress induced-senescent 
IMR90 cells.  
As shown in Figure 11, replicative senescent cells display a 
significant decrease of H3K4me3 in the promoters of LIMA1, 
MAGOHA, and MAGOHB, when compared to young cells. At the 
same time, the amounts of H3K27me3 were significantly increased. 
Our results also show a significant enrichment of H3K27me3 on the 
promoter of LEPRE1, whereas no changes in H3K4me3 amount were 
observed on the same region. 
In DEM-senescent cells, analysis of local H3K4me3 and H3K27me3 
distributions demonstrated that H3K4me3 occupancy on LEPRE1 and 
LIMA1 promoters was unchanged, but strongly decreased on 
MAGOHA and MAGOHB promoters. On the contrary, increased 
recruitment of H3K27me3 was found on the promoter regions of 
LEPRE1, LIMA1 and MAGOHA genes. 
These results suggest that local changes in the H3 methylation states 
are involved in the reduced expression of LEPRE1, LIMA1, 
MAGOHA, and MAGOHB genes observed during senescence of 
IMR90 cells.  
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Figure 11: Analysis of H3K4me3 and H3K27me3 states on LEPRE1, LIMA1, 
MAGOHA and MAGOHB promoters in IMR90 senescent cells. H3K4me3 or 
H3K27me3 occupancy in the promoter regions (within 500 bp from the start site of 
the genes) of LEPRE1, LIMA1, MAGOHA and MAGOHB in replicative senescent 
cells (PDL58) or in young cells treated with DEM (100 µM) for 10 days were 
compared to young cells by ChiP-qPCR assays. The relative H3K4me3 or 
H3K27me3 mark occupancy for each promoter after ChiP was calculated based on 
the threshold cycle (Ct) values (see Materials and Methods section). Data are 
expressed by assigning the arbitrary value 1 to the occupancy of the marks observed 
in young IMR90 cells. Each column represents the mean ± SD of 3 independent cell 
populations; *p ≤ 0.05. 
Figure 11 
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4. Discussion 
 
Molecular program leading to cellular senescence is largely mediated 
by gene expression changes acting at transcriptional and post-
transcriptional levels as well at epigenetic level. 
miRNAs regulate gene expression post-transcriptionally by inducing 
degradation or translation repression of target mRNAs. 
In a previous study, we demonstrated that miR-494 is up-regulated in 
senescent IMR90 human diploid fibroblasts and its ectopic expression 
in young cells induces premature senescence (28). Therefore, we used 
a high-throughput proteomic approach to screen for miR-494 targets. 
The 2D-DIGE coupled to MS let us to identify 121 down-regulated 
protein species and among these, by functional assays we 
demonstrated that hnRNPA3, PDIA3, RAD23B and SYNCRIP are 
direct targets of miR-494. Our results further showed that siRNA-
mediated knockdown of hnRNPA3 or RAD23B foster senescence of 
IMR90 cells. Importantly, we also demonstrated that ectopic 
expression of hnRNPA3 or RAD23B prevented, at least in part, the 
senescent phenotype induced by miR-494 in young IMR90 cells.  
hnRNPA3 belongs to the hnRNPA/B family, involved in the 
regulation of the splicing process (73). hnRNPA3 interacts with HuR, 
another RNA-binding protein involved in cellular senescence (74) and 
several reports have demonstrated that hnRNPA3 binds to telomeres 
(75,76). Of note, our data indicate that hnRNPA3 down-regulation is 
involved in replicative senescence of both IMR90 and WI38 cells, 
which is triggered by telomere attrition.  
RAD23B was characterized as key component of the XPC-nucleotide 
excision repair (NER) complex. In addition, it is a member of the 
Oct4/Sox2 transcriptional coactivator complex (77) and is involved in 
the regulation of ubiquitin-mediated proteolytic process (78) thus 
affecting a variety of pathways, including stress responses. Therefore, 
it is plausible that, miR-494-mediated RAD23B down-regulation, 
negatively affects these functions, thus generating a signal for the 
senescence program. Of note, in stress-induced senescence, RAD23B 
is particularly reduced.   
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The other two direct targets of miR-494 were proved to be PDIA3 and 
SYNCRIP.  For PDIA3, we could not functionally correlate its down-
regulation to the senescence program in IMR90 cells, because siRNA 
experiments resulted in a cytotoxic effect. On the contrary, the results 
obtained for SYNCRIP demonstrated that its down-regulation by 
siRNA is not causally involved in the senescence process. 
In conclusion, the studies aimed to identify direct targets of miR-494, 
reveal four novel genes that are post-transcriptionally regulated by this 
microRNA. Among them, we demonstrated that hnRNPA3 and 
RAD23B are effectors of the miR-494-induced senescent phenotype 
and this program involves activation of the p53/p21 pathway. 
Importantly, the presence of one of them is indeed sufficient to hamper 
the senescence induced by miR-494.  
For the other studies, aimed to identify common regulators of 
senescence, we also applied the technology of 2D-DIGE coupled to 
MS analysis. By profiling quantitative proteomic changes occurring 
both in replicative and stress-induced senescence of human IMR90 
fibroblasts, we found that twenty protein spots shifted their 
quantitative representation in the same direction (over- or down-
represented) in both conditions of senescence. Our study also 
identified proteins, such as vimentin, cathepsin B, COL1A1, COL1A2 
and XRCC5/Ku80, which previous proteomic studies in other cellular 
systems already identified as modified during senescence (79-85). 
Among the 25 sequence entries obtained from MS analysis, we 
identified a set of proteins whose decreased representation is 
associated with the down-regulation of the corresponding mRNAs, 
thus indicating that the regulation of these genes during senescence 
occurs at a transcriptional level. Functional studies of 10 genes by 
siRNAs in IMR90 cells demonstrated, for the first time, that LEPRE1, 
LIMA1/EPLIN, MAGOHA and MAGOHB genes are causally 
involved in the induction of cellular senescence.  
LEPRE1 is a member of the prolyl 3-hydroxylase family, implicated in 
the hydroxylation of type I collagen. Inactivation of its gene in mice 
leads to tendon, skin and bones abnormalities (86), whereas gene 
mutations are implicated in osteogenesis imperfecta type VIII (87). 
Very recently, the activity of LEPRE1 as disulfide isomerase has been 
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reported, thus emphasizing its more general protective function in the 
cell homeostasis (88).  
LIMA1 is a cytoskeleton-associated protein, frequently lost or down-
regulated in human cancer (89-91). The fact that siRNA-mediated 
LIMA1 down-regulation results in premature senescence, may 
represent a mechanism adopted by normal cells to antagonize the 
tumor development in pre-cancerous cells, as described for 
inactivation of other tumor suppressors, such as PTEN, VHL, NF1 and 
RB, (49,58,92).  
MAGOH, Mago-Nashi Homolog, proliferation-associated 
(Drosophila) protein is a component of the core exon junction complex 
(EJC) (93) involved in splicing, mRNA export, nonsense-mediated 
mRNA decay (NMD) pathway, and translation initiation (94,95). In 
humans exist two genes (MAGOHA and MAGOHB) that encode 
protein isoforms differing only in the first four amino acids (96), 
indicating that gene redundancy is probably related to an important 
function of this protein. MAGOH in mice indeed controls brain size by 
regulating the mRNA levels of LIS1, a master gene for brain 
development (97). Of note, we found that both MAGOHA and 
MAGOHB mRNAs are down-regulated in senescence and that siRNA-
mediated repression of one isoform is sufficient to drive prematurely 
senescence involving up-regulation of p53. In fact, as already 
demonstrated by others in the case of MAGOH mutants (97), our 
experiments suggest that MAGOH depletion should provoke defective 
cell division that may result in DNA damage accumulation.  
We reported that the expression levels of LEPRE1, LIMA1, 
MAGOHA, and MAGOHB genes are down-regulated also in other 
models of senescence in vitro (i. e. senescent WI38 cells) and in vivo 
by testing several cell lines of human fibroblasts from young (age 21–
24) or old (age 87–94) subjects. These results let to foresee a possible 
marker role of these genes/proteins in the progression of aging and 
possibly to follow up age-related conditions. 
Considering the role of histone methylation states in transcriptional 
regulation (14-18, 35-40), we explored de novo distribution of 
H3K4me3 and H3K27me3 at the level of the promoter regions of 
LEPRE1, LIMA1, MAGOHA, and MAGOHB genes during 
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senescence. We found an increase of the repressive H3K27me3 mark 
and a significant decrease, in most cases, of active H3K4me3 mark on 
the promoters of LEPRE1, LIMA1, MAGOHA and MAGOHB gene. 
This phenomenon well correlated with their decreases at mRNA 
levels. The role of key enzymes responsible of H3K4 and H3K27 
methylation/demethylation changes requires further investigation.  
In conclusion, we have identified novel proteins. namely hnRNPA3, 
RAD23B (as direct miR-494 targets), LEPRE1, LIMA1, MAGOHA, 
and MAGOHB that, being down-regulated in cellular senescence, may 
represent crucial components of the cellular senescence response.  
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